[NEU] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 37.16%
YoY- 42.40%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 CAGR
Revenue 495 13,990 631 2,988 61 1,506 2,047 -21.32%
PBT -3,426 7,169 6,840 -3,773 -8,409 -3,645 -7,381 -12.16%
Tax -495 0 0 863 360 -4 -5 117.38%
NP -2,931 7,169 6,840 -4,636 -8,049 -3,641 -7,374 -14.43%
Tax Rate - 0.00% 0.00% - - - - -
Total Cost 3,426 6,821 -6,209 7,624 8,110 5,147 9,421 -15.71%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 CAGR
NP Margin -592.12 51.24 1,083.99 -155.15 -13,195.08 -241.77 -360.23 8.76%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 CAGR
EPS -0.03 0.07 0.07 -0.06 -0.09 -0.05 -0.11 -19.71%
EPS Diluted -0.03 0.07 0.07 -0.06 -0.09 -0.05 -0.11 -19.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.